Search
for

    Sort by

    Research 31–60 of 111

    1. Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period The Journal of Urology · 2006 · 32 citations
    2. CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? The Journal of Sexual Medicine · 2013 · 29 citations
    3. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    4. Endocrine treatment of benign prostatichypertrophy: Current concepts Urology · 1991 · 11 citations
    5. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    6. Bioavailability File: Bicalutamide Fabad Journal of Pharmaceutical Sciences · 2025
    7. 1994 Forthcoming educational events European Journal of Cancer · 1994
    8. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    9. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review The European Journal of Contraception & Reproductive Health Care · 2017 · 11 citations
    10. Treatment of androgen excess in females: Yesterday, today and tomorrow Gynecological Endocrinology · 1997 · 9 citations
    11. Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes SPIRE - Sciences Po Institutional REpository · 2023
    12. Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens 2017
    13. Medical Treatment of Hepatocellular Carcinoma: Any Progress? Tumori Journal · 1994 · 19 citations
    14. HAIR REGROWTH Dermatologic Clinics · 1998 · 118 citations
    15. Doxetaxel: new indication. Prostate cancer: a few more weeks. PubMed · 2006
    16. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy The Journal of Urology · 2024 · 4 citations
    17. Androgen biosynthetic pathways in the human prostate 2008 · 160 citations
    18. Tamoxifen for flutamide/finasteride-induced gynecomastia Urology · 1997 · 49 citations
    19. Cardiovascular effects of hormone therapy for prostate cancer Drug Healthcare and Patient Safety · 2015 · 18 citations
    20. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol BMC Cancer · 2024 · 4 citations
    21. News & Notes Trends in Urology Gynaecology & Sexual Health · 2008
    22. Inhibitory influence of agmatine on catamenial-like seizure susceptibility in progesterone withdrawn female rats Brain disorders · 2024
    23. Congenital Adrenal Hyperplasia Journal of Pediatric and Adolescent Gynecology · 2017 · 88 citations
    24. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? Dermatology Online Journal · 2009 · 39 citations
    25. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    26. The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015 Endocrine Reviews · 2024 · 10 citations
    27. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    28. Antiandrogens as Therapies for COVID-19: A Systematic Review Cancers · 2024 · 6 citations
    29. Connarus semidecandrus Jack Exerts Anti-Alopecia Effects by Targeting 5α-Reductase Activity and an Intrinsic Apoptotic Pathway Molecules · 2022 · 2 citations
    30. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship Dermatology Online Journal · 2009